Mitani K - Search Results

1

Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study.

Ogata K, Kakumoto K, Matsuda A, Tohyama K, Tamura H, Ueda Y, Kurokawa M, Takeuchi J, Shibayama H, Emi N, Motoji T, Miyazaki Y, Tamaki H, Mitani K, Naoe T, Sugiyama H, Takaku F. Ogata K, et al. Among authors: mitani k. Leuk Res. 2012 Oct;36(10):1229-36. doi: 10.1016/j.leukres.2012.05.006. Epub 2012 Jun 7. Leuk Res. 2012. PMID: 22682984

2

Serum erythropoietin titers in hematological malignancies and related diseases.

Urabe A, Mitani K, Yoshinaga K, Iki S, Yagisawa M, Ohbayashi Y, Takaku F. Urabe A, et al. Among authors: mitani k. Int J Cell Cloning. 1992 Nov;10(6):333-7. doi: 10.1002/stem.5530100604. Int J Cell Cloning. 1992. PMID: 1460322 Free article.

3

Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia.

Mitani K, Miyazono K, Urabe A, Takaku F. Mitani K, et al. Cancer Genet Cytogenet. 1989 Jun;39(2):299-300. doi: 10.1016/0165-4608(89)90196-9. Cancer Genet Cytogenet. 1989. PMID: 2752380 No abstract available.

4

An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.

Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H. Tanaka T, et al. Among authors: mitani k. EMBO J. 1995 Jan 16;14(2):341-50. doi: 10.1002/j.1460-2075.1995.tb07008.x. EMBO J. 1995. PMID: 7530657 Free PMC article.

5

Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.

Tanaka K, Tanaka T, Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Hirai H. Tanaka K, et al. Among authors: mitani k. Biochem Biophys Res Commun. 1995 Jun 26;211(3):1023-30. doi: 10.1006/bbrc.1995.1913. Biochem Biophys Res Commun. 1995. PMID: 7598688

6

Growth inhibition of leukaemic cells carrying the t(3;21) by the AML1/EVI-1-specific antisense oligonucleotide.

Mitani K, Ogawa S, Tanaka T, Kurokawa M, Yazaki Y, Hirai H. Mitani K, et al. Br J Haematol. 1995 Jul;90(3):711-4. doi: 10.1111/j.1365-2141.1995.tb05606.x. Br J Haematol. 1995. PMID: 7647015

7

The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.

Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON, Hirai H. Kurokawa M, et al. Among authors: mitani k. Oncogene. 1995 Sep 7;11(5):833-40. Oncogene. 1995. PMID: 7675444

8

Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.

Kurokawa M, Tanaka T, Tanaka K, Ogawa S, Mitani K, Yazaki Y, Hirai H. Kurokawa M, et al. Among authors: mitani k. Oncogene. 1996 Feb 15;12(4):883-92. Oncogene. 1996. PMID: 8632911

9

Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.

Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: mitani k. Leukemia. 1996 May;10(5):788-94. Leukemia. 1996. PMID: 8656673

10

Overexpression of Evi-1 and dysmegakaryopoiesis in human leukemias: reply to Carapeti, Goldman and Cross, Leukemia 1996; 10: 1561.

Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: mitani k. Leukemia. 1996 Nov;10(11):1849. Leukemia. 1996. PMID: 8892696 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters